CHRO · Categories · Form 3

CHRO - SEC Form 3 initial insider statements

Channel Therapeutics Corporation (CHRO) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.

Recent Form 3 for CHRO

• 336d
  SEC Form 3 filed by new insider Greenleaf Peter

  3 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 336d
  SEC Form 3 filed by new insider Pauls Matthew

  3 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 336d
  SEC Form 3 filed by new insider Baxter Richard B

  3 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 341d
  SEC Form 3 filed by new insider Ligand Pharmaceuticals Inc

  3 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 706d
  Amendment: New insider Francis Knuettel Ii claimed ownership of 130,953 shares (SEC Form 3)

  3/A - Chromocell Therapeutics Corp (0001919246) (Issuer)

Other CHRO categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends